ENVX Stock Analysis: Enovix | NASDAQ
Electrical Equipment & Parts | NASDAQ, USA | Market Cap: 912m USD | 12M Return: -62.1% | US2935941078 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 26.2M
Qual. Beats: 0
Rev. Trend: 86.0%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 5.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Enovix Corporation is a U.S.-based designer, developer, and manufacturer of lithium-ion battery cells, operating both domestically and internationally. The company serves end markets including wearables and IoT, smartphones, computing, electric vehicles, and OEMs. Founded in 2006, Enovix is headquartered in Fremont, California, and is listed on NASDAQ under the ticker ENVX.
Within the broader lithium-ion battery sector, Enovix is part of the global push toward higher energy density storage solutions, driven largely by rising demand from electric vehicles and portable electronics. The company differentiates its business model by focusing on advanced cell architecture and U.S.-based manufacturing, positioning it within the reshoring trend for critical battery supply chains.
- Smartphone OEM design wins drive near-term revenue growth
- Manufacturing scale-up increases cash burn and dilution risk
- EV battery program commercialization remains key long-term catalyst
| Net Income: -171.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.12 > 0.02 and ΔFCF/TA 24.00 > 1.0 |
| NWC/Revenue: 1.48k% < 20% (prev 927.4%; Δ 551.5% < -1%) |
| CFO/TA -0.13 > 3% & CFO -111.5m > Net Income -171.5m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 10.97 > 1.5 & < 3 |
| Outstanding Shares: last quarter (217.4m) vs 12m ago 13.63% < -2% |
| Gross Margin: -48.63% > 18% (prev -36.82%; Δ -11.81% > 0.5%) |
| Asset Turnover: 5.15% > 50% (prev 4.59%; Δ 0.56% > 0%) |
| Interest Coverage Ratio: -5.42 > 6 (EBIT TTM -145.7m / Interest Expense TTM 26.9m) |
| A: 0.61 (Total Current Assets 558.5m - Total Current Liabilities 50.9m) / Total Assets 833.9m |
| B: -1.22 (Retained Earnings -1.02b / Total Assets 833.9m) |
| C: -0.22 (EBIT TTM -145.7m / Avg Total Assets 666.5m) |
| D: 0.41 (Book Value of Equity 240.7m / Total Liabilities 591.2m) |
| Altman-Z'' = -1.02 = CCC |
| DSRI: 0.63 (Receivables 3.94m/4.15m, Revenue 34.3m/22.9m) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 1.18 (AQ_t 0.12 / AQ_t-1 0.10) |
| SGI: 1.50 (Revenue 34.3m / 22.9m) |
| TATA: -0.07 (NI -171.5m - CFO -111.5m) / TA 833.9m) |
| Beneish M = -2.87 (Cap -4..+1) = A |
As of August 07, 2026, the stock is trading at USD 4.26 with a total of 4,270,467 shares traded. Over the past week, the price has changed by +1.91%, over one month by -24.20%, over three months by -36.32% and over the past year by -62.07%.
Current recommended Stop Loss: 3.70 (which is 13.1% or 1.5 ATR below the current price).
Enovix has received a consensus analysts rating of 4.54. Therefore, it is recommended to buy ENVX.
- StrongBuy: 9
- Buy: 2
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 13 | 204% |
P/S = 26.5676
P/B = 3.3311
Revenue TTM = 34.3m USD
EBIT TTM = -145.7m USD
EBITDA TTM = -109.7m USD
Long Term Debt = 520.2m USD (from longTermDebt, last quarter)
Short Term Debt = 9.44m USD (from shortTermDebt, last quarter)
Debt = 551.4m USD (from shortLongTermDebtTotal, last quarter) + Leases 10.9m
Net Debt = 22.7m USD (calculated: Debt 551.4m - CCE 528.7m)
Enterprise Value = 934.6m USD (911.9m + Debt 551.4m - CCE 528.7m)
Interest Coverage Ratio = -5.42 (Ebit TTM -145.7m / Interest Expense TTM 26.9m)
EV/FCF = -9.22x (Enterprise Value 934.6m / FCF TTM -101.4m)
FCF Yield = -10.85% (FCF TTM -101.4m / Enterprise Value 934.6m)
FCF Margin = -295.3% (FCF TTM -101.4m / Revenue TTM 34.3m)
Net Margin = -499.6% (Net Income TTM -171.5m / Revenue TTM 34.3m)
Gross Margin = -48.63% ((Revenue TTM 34.3m - Cost of Revenue TTM 51.0m) / Revenue TTM)
Gross Margin QoQ = -102.9% (prev 11.65%)
Tobins Q-Ratio = 1.12 (Enterprise Value 934.6m / Total Assets 833.9m)
Interest Expense / Debt = 4.88% (Interest Expense 26.9m / Debt 551.4m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -115.1m (EBIT -145.7m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 8.48 (Total Current Assets 558.5m / Total Current Liabilities 65.8m)
Debt / Equity = 2.29 (Debt 551.4m / totalStockholderEquity, last quarter 240.7m)
Debt / EBITDA = -0.21 (negative EBITDA) (Net Debt 22.7m / EBITDA -109.7m)
Debt / FCF = -0.22 (negative FCF - burning cash) (Net Debt 22.7m / FCF TTM -101.4m)
Total Stockholder Equity = 252.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -25.73% (Net Income -171.5m / Total Assets 833.9m)
RoE = -67.92% (Net Income TTM -171.5m / Total Stockholder Equity 252.5m)
RoCE = -18.86% (EBIT -145.7m / Capital Employed (Equity 252.5m + L.T.Debt 520.2m))
RoIC = -14.56% (negative operating profit) (NOPAT -115.1m / Invested Capital 790.7m)
WACC = 13.52% (E(911.9m)/V(1.46b) * Re(19.37%) + D(551.4m)/V(1.46b) * Rd(4.88%) * (1-Tc(0.21)))
Discount Rate = 19.37% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 98.63 | Cagr: 12.82%
[DCF] Fair Price = unknown (Cash Flow -101.4m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.28 | # QB: 0
Revenue Correlation: 85.98 | Revenue CAGR: 205.9% | SUE: 1.20 | # QB: 1
EPS current Quarter (2026-06-30): EPS=-0.15 | Chg30d=+0.00% | Revisions=+22% | Analysts=9
EPS next Quarter (2026-09-30): EPS=-0.14 | Chg30d=+0.00% | Revisions=+18% | Analysts=9
EPS current Year (2026-12-31): EPS=-0.56 | Chg30d=+0.00% | Revisions=+50% | GrowthEPS=-4.6% | GrowthRev=+27.2%
EPS next Year (2027-12-31): EPS=-0.57 | Chg30d=+0.00% | Revisions=-30% | GrowthEPS=-1.3% | GrowthRev=+125.2%
[Analyst] Revisions Ratio: +19% (up=17, down=11)